Fractyl Health’s Post

View organization page for Fractyl Health, graphic

7,355 followers

We are delighted to share today's The Wall Street Journal article featuring Fractyl Health, Inc. (Nasdaq: GUTS). Dr. Harith Rajagopalan, Fractyl Health's CEO, is quoted throughout Betsy McKay's article "The Quest for Treatments to Keep Weight Off After Ozempic." In it, he says, "The unmet need has shifted from how do you lose weight to how do you keep it off." Uniquely positioned in the market, Fractyl Health is working on two therapies, Revita® and Rejuva®, to help people keep the weight off. https://lnkd.in/g8QrnVDc   #BioTech #Innovation #Obesity #Type2Diabetes     *In the United States, Revita is for investigational use only under US law.   **The Rejuva platform is in preclinical development and has not yet been evaluated by regulatory agencies for investigational or commercial use. 

The Quest for Treatments to Keep Weight Off After Ozempic

The Quest for Treatments to Keep Weight Off After Ozempic

wsj.com

Karonne Brennman

Senior Executive Recruiter

3mo

Amazing strides

To view or add a comment, sign in

Explore topics